Michael A Nalls Selected Research

Michael A Nalls Research Topics

Disease

6	Dementia (Dementias) 01/2018 - 01/2012
5	Parkinson Disease (Parkinson's Disease) 12/2017 - 02/2011
4	Cognitive Dysfunction 01/2021 - 01/2012
3	Stroke (Strokes) 01/2018 - 08/2011
3	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 01/2010
3	Obesity 11/2015 - 09/2014
3	Coronary Disease (Coronary Heart Disease) 05/2013 - 08/2011
2	Frontotemporal Dementia (Semantic Dementia) 10/2018 - 05/2014
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2018 - 05/2014
2	Hypertension (High Blood Pressure) 05/2017 - 06/2011
2	Type 2 Diabetes Mellitus (MODY) 01/2017 - 07/2016
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 09/2014
2	Ischemic Stroke 03/2013 - 01/2013
2	Gout 02/2013 - 10/2011
1	Hereditary Diffuse Leukoencephalopathy with Spheroids 01/2018
1	Infarction (Infarctions) 01/2018
1	Leukoencephalopathies 01/2018
1	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 01/2018
1	Weight Gain 11/2015
1	Myasthenia Gravis 04/2015
1	Autoimmune Diseases (Autoimmune Disease) 04/2015
1	Insulin Resistance 09/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2014
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2013
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2013
1	Tauopathies 07/2013
1	Lewy Body Disease (Lewy Body Dementia) 06/2013
1	Cerebral Hemorrhage 03/2013
1	Arthritis (Polyarthritis) 02/2013
1	Emphysema 01/2013
1	CADASIL 01/2013
1	Rheumatoid Arthritis 03/2012
1	Inflammation (Inflammations) 03/2012
1	Cataract (Cataracts) 06/2011
1	Non-alcoholic Fatty Liver Disease 03/2011
1	Fibrosis (Cirrhosis) 03/2011
1	Crohn Disease (Crohn's Disease) 01/2011
1	Disease Progression 05/2009

Drug/Important Bio-Agent (IBA)

3	Apolipoproteins E (ApoE)IBA 01/2021 - 05/2012
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 05/2014
3	Mitochondrial DNA (mtDNA)IBA 02/2014 - 01/2012
2	DNA (Deoxyribonucleic Acid)IBA 12/2017 - 04/2015
2	Glucose (Dextrose)FDA LinkGeneric 07/2016 - 06/2011
2	Amyloid (Amyloid Fibrils)IBA 01/2016 - 02/2014
2	LipidsIBA 02/2015 - 03/2011
2	CholesterolIBA 09/2014 - 10/2013
2	RNA (Ribonucleic Acid)IBA 05/2014 - 01/2010
2	Uric Acid (Urate)IBA 02/2013 - 10/2011
2	EnzymesIBA 04/2012 - 01/2010
2	ChemokinesIBA 01/2011 - 05/2009
1	HLA-DRB1 Chains (HLA DRB1)IBA 10/2018
1	Untranslated RNA (Noncoding RNA)IBA 10/2018
1	Eukaryotic Initiation Factor-2B (Eukaryotic Initiation Factor 2B)IBA 01/2018
1	Angiotensin IIIBA 05/2017
1	Messenger RNA (mRNA)IBA 05/2017
1	Biological FactorsIBA 05/2017
1	alpha-2-HS-GlycoproteinIBA 01/2017
1	Insulin (Novolin)FDA Link 07/2016
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2015
1	Cholinergic ReceptorsIBA 04/2015
1	Immunomodulating AgentsIBA 04/2015
1	Glutamic Acid (Glutamate)FDA Link 02/2015
1	Phosphotransferases (Kinase)IBA 12/2014
1	GTP Phosphohydrolases (GTPases)IBA 12/2014
1	C-Reactive ProteinIBA 09/2014
1	DNA-Binding Proteins (DNA Binding Protein)IBA 05/2014
1	Interferon Type IIBA 10/2013
1	Protein Isoforms (Isoforms)IBA 07/2013
1	Glucosylceramidase (Glucocerebrosidase)IBA 06/2013
1	Chemokine Receptor D6IBA 05/2013
1	ribophorinIBA 05/2013
1	Cysteine (L-Cysteine)FDA Link 01/2013
1	Amino Acids FDA Link 01/2013
1	GlobulinsIBA 01/2013
1	Interleukin-6 (Interleukin 6)IBA 03/2012
1	Monoclonal AntibodiesIBA 03/2012
1	tocilizumab (atlizumab)FDA Link 03/2012
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 03/2012
1	Histone Deacetylases (Histone Deacetylase)IBA 02/2012
1	HomocysteineIBA 08/2011
1	Folic Acid (Vitamin M)FDA LinkGeneric 08/2011
1	HDL LipoproteinsIBA 06/2011
1	Triglycerides (Triacylglycerol)IBA 06/2011
1	migenIBA 03/2011
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2011
1	InterleukinsIBA 01/2011
1	Antigen Receptors (Antigen Receptor)IBA 05/2009

Therapy/Procedure

3	Therapeutics 01/2018 - 02/2011
1	Lenses 06/2011